{
 "name": "永立榮",
 "slug": "tw-6973",
 "aliases": [
  "永立榮生醫股份有限公司",
  "U-Neuron",
  "6973"
 ],
 "ticker": "6973",
 "industry": "生技醫療業",
 "website": "https://www.u-neuron.com/",
 "summary": "永立榮（6973）是興櫃的生技醫療類股公司，2015 年成立，2023 年登錄興櫃。基本資料取自臺灣證券交易所／證券櫃檯買賣中心公開資料；重大訊息見 https://drugnews.com.tw/filings/ 。",
 "facts": [
  {
   "claim": "公司全名",
   "value": "永立榮生醫股份有限公司",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "英文簡稱",
   "value": "U-Neuron",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "產業類別",
   "value": "生技醫療業",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "掛牌市場",
   "value": "證券櫃檯買賣中心興櫃",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "登錄興櫃日期",
   "value": "2023-07-20",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "成立日期",
   "value": "2015-09-04",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "董事長",
   "value": "簡奉任",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "總經理",
   "value": "黃效民",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "實收資本額",
   "value": 408030000,
   "unit": "新台幣元",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "簽證會計師事務所",
   "value": "資誠聯合會計師事務所",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "公司網址",
   "value": "https://www.u-neuron.com/",
   "unit": "",
   "as_of": "2026-10-21",
   "source": "https://www.tpex.org.tw/openapi/v1/mopsfin_t187ap03_R"
  },
  {
   "claim": "管線：UA002（同種異體羊水幹細胞）",
   "value": "口服藥無效之男性勃起功能障礙｜第2a期已完成收案｜地區未揭露",
   "unit": "",
   "as_of": "2026-06-24",
   "source": "https://mops.twse.com.tw/mops/#/web/t05st01",
   "note": "MOPS 6973／115年全年度／發言日期2026-06-24 18:17:04；主旨：本公司同種異體羊水幹細胞新藥UA002治療口服藥無效之男性勃起功能障礙，臨床2a試驗已完成收案。標題已讀；未據此推定試驗完成或核准上市。"
  },
  {
   "claim": "管線：UB003（外泌體眼科療法）",
   "value": "乾眼症／神經營養性角膜炎｜CMC／臨床前／PIND準備｜地區未揭露",
   "unit": "",
   "as_of": "2026-05-15",
   "source": "https://www.u-neuron.com/新藥開發-2/",
   "note": "官網新藥頁，WordPress公開API /wp-json/wp/v2/pages/17321 的date=2026-05-15，modified=2026-08-10；as_of依發布日，非查核日。地區未明者明列未揭露。"
  },
  {
   "claim": "催化劑：UA002",
   "value": "Phase 2b雙盲試驗（療效驗證）規劃｜2027（公司預估）｜已公告",
   "unit": "",
   "as_of": "2026-05-15",
   "source": "https://www.u-neuron.com/新藥開發-2/",
   "note": "官網新藥頁，WordPress公開API /wp-json/wp/v2/pages/17321 的date=2026-05-15，modified=2026-08-10；as_of依發布日，非查核日。地區未明者明列未揭露。 只保留原文年度，未細化為季度或日期。"
  }
 ],
 "responses": [],
 "provided_by": "public_sources",
 "verified_by": "Drugnews｜藥時事",
 "verified_at": "2026-10-22",
 "disclosure": "Drugnews 依公開來源（公司公告、公開資訊觀測站、試驗登錄、主管機關文件）整理，於 verified_at 逐條核對來源；未經公司審閱。",
 "url": "https://drugnews.com.tw/companies/tw-6973.json",
 "generated_at": "2026-10-23T11:48:56.615Z"
}